ChemoCentryx Inc (NASDAQ:CCXI)

9.30
Delayed Data
As of 4:00pm ET
 -0.17 / -1.80%
Today’s Change
5.42
Today|||52-Week Range
10.80
+56.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$461.8M

Company Description

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company, which engages in commercialization and development of pharmaceutical products. It focuses on discovering, developing, and commercializing therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders, and cancer. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

Contact Information

ChemoCentryx, Inc.
850 Maude Avenue
Mountain View California 94043
P:(650) 210-2900
Investor Relations:

Employees

Shareholders

Individual stakeholders44.61%
Other institutional32.70%
Mutual fund holders16.64%

Top Executives

Thomas J. SchallChairman, President & Chief Executive Officer
William FaireyChief Operating Officer & Executive Vice President
Susan M. KanayaCFO, Secretary, CAO & Principal Accounting Officer
Rajinder SinghSenior Vice President-Research
Markus J. CappelTreasurer & Chief Business Officer